Abstract Methylation is an important event in the biotransformation pathway for many drugs and xenobiotic compounds. We screened DNA from 48 Japanese individuals for single-nucleotide polymorphisms (SNPs) in six methyltransferase ( These variants may contribute to a more precise understanding of possible correlations between genotypes and disease-susceptibility phenotypes or risk for side effects from drugs.
Introduction
Methylation is an important feature of the biotransformation pathway for many drugs and xenobiotic compounds (Weinshilboum 1989) . The reaction involves transfer of the activated methyl group of S-adenosyl-l-methionine (AdoMet) to the substrates.
Among the enzymes involved in such reactions, called methyltransferases, catechol-O-methyltransferase (COMT; EC 2.1.1.6) catalyzes the transfer of a methyl group from Sadenosylmethionine to catecholamines, a class of molecules that includes the neurotransmitters dopamine, epinephrine, and norepinephrine (Kopin 1985) . O-methylation drives one of the major pathways for degrading catecholamine transmitters (Zhu and Conney 1998) . In addition to its role in the metabolism of endogenous substances, COMT is important for metabolizing catechol drugs such as L-DOPA (Lautala et al. 2001) . COMT is found in two forms in tissues, a cytoplasmic soluble form (S-COMT) and a membrane-bound form (MB-COMT) located in the rough endoplasmic reticulum (Salminen et al. 1990; Bertocci et al. 1991; Lundström et al. 1991; Ulmanen et al. 1997) . The soluble enzyme appears to be the predominant form of COMT in most tissues. However, in humans the membranebound enzyme predominates in the brain and adrenal medulla, and also in pheochromocytomas (Tenhunen et al. 1994; Eisenhofer et al. 1998 ). The MB-COMT transcript differs from the S-COMT transcript in that the former contains a longer 5Ј untranslated region (UTR) and its translation-start site lies 50 codons upstream from that of S-COMT (Tenhunen et al. 1994) . Lotta et al. (1995) identified a G to A polymorphism in the COMT gene at codon 158, which leads to substitution of methionine for valine. This polymorphism is associated with a three-to fourfold difference in enzymatic activity (Lachman et al. 1996) ; i.e., homozygosity for the A allele, COMT Met , is associated with low enzyme activity and thermolability. Individuals who are homozygous for the normal (valine) allele display relatively high activity and heat stability of COMT; heterozygotes usually display intermediate levels of COMT activity and heat stability.
Guanidinoacetate methyltransferase (GAMT; EC2.1.1.2) catalyzes the last step of creatine biosynthesis in mammals. Creatine is an important metabolite for cellular energy metabolism in a variety of tissues, e.g., skeletal, cardiac and smooth muscle, and brain (Walker 1979; Wallimann and Hemmer 1994) . GAMT deficiency causes an inborn error in creatine biosynthesis (Stöckler et al. 1994 (Stöckler et al. , 1996a (Stöckler et al. , 1996b (Stöckler et al. , 1997 Carducci et al. 2000; Ilas et al. 2000) . Deficiency of GAMT readily explains the accumulation of guanidinoacetate and the depletion of the total creatine pool in affected individuals.
Histamine N-methyltransferase (HNMT; EC 2.1.1.8) catalyzes a major metabolic pathway of histamine, a known neurotransmitter (Schwartz et al. 1991) . Histamine plays an important role in allergic responses and is involved in regulating secretion of gastric acid (Wasserman 1983; Loiselle and Wollin 1993) . Biochemical genetic studies of HNMT in human red blood cells demonstrated fivefold individual differences in the level of this enzyme's activity, mainly reflecting common genetic polymorphisms (Scott et al. 1988; Price et al. 1993) . Preuss et al. (1998) demonstrated a C314T polymorphism in exon 4 in the HNMT gene that resulted in a Thr105Ile amino acid substitution; they found that the T314 allele was associated with decreased levels of both HNMT enzymatic activity and immunoreactive protein. Therefore, the presence of a T314 allele would be expected to result in reduced histamine metabolism and increased bronchoconstriction. A number of investigators have examined potential associations of HNMT genotypes with altered susceptibilities to various diseases such as asthma (Yan et al. 2000a ) and schizophrenia (Yan et al. 2000b) .
Nicotinamide N-methyltransferase (NNMT; EC 2.1.1.1) catalyzes the N-methylation of nicotinamide and other pyridines to form pyridinium ions (Rini et al. 1989 ). Several diseases have been associated with abnormal nicotinamide metabolism that results in elevated levels of Nmethylnicotinamide; these include idiopathic Parkinson's disease (Williams et al. 1993 ) and hepatic cirrhosis (Cuomo et al. 1994) . NNMT enzymatic activity in human liver varies in a fivefold range, with a bimodal frequency distribution (Rini et al. 1989 ). Phenotypic differences in NNMT activity could reflect genetic polymorphisms; however, no sequence differences were seen when investigators compared cDNAs of individuals with high and low NNMT activity (Smith et al. 1998; Yan et al. 1999) .
Phosphatidylethanolamine N-methyltransferase (PEMT; EC2.1.1.17) converts phosphatidylethanolamine to phosphatidylcholine in mammalian liver . Immunolocalization experiments have detected two isoforms of PEMT, encoded by a single gene . PEMT1, which constitutes the majority of PEMT activity, is located at the endoplasmic reticulum (Vance and Ridgway 1988) , while PEMT2 is found on mitochondriaassociated membranes (Cui et al. 1993) . The activity of PEMT is very low when hepatocytes are undifferentiated and proliferating rapidly. At birth, as hepatocyte proliferation slows and final differentiation begins, PEMT2 expression increases dramatically. When hepatocyte proliferation was induced in adult rats by partial hepatectomy, PEMT2 expression was inhibited . Those results suggested that this enzyme might play a role in the regulation of hepatocyte growth and cell division (Walkey et al. 1999) .
Phenylethanolamine N-methyltransferase (PNMT; EC 2.1.1.28) catalyzes the final step in the catecholamine biosynthetic pathway, converting norepinephrine to epinephrine (Axelrod and Weinshilboum 1972) . It is primarily expressed in the adrenal medulla and the retina (Baetge et al. 1988) . Its activity increases after stress in response to glucocorticoids and neuronal stimulation (Betito et al. 1994) . Since defects in epinephrine metabolism have been implicated in the etiology of attention-deficit hyperactivity disorder (ADHD), aggression, and anxiety (Klinteberg and Magnusson 1989; Pliszka et al. 1994; Girardi et al. 1995; Hanna et al. 1996) , PNMT is considered to be a candidate for a range of psychiatric disorders.
To investigate the nature of apparent genotype/phenotype correlations for methyltransferases more precisely, we began by searching for additional single-nucleotide polymorphisms (SNPs) in the six methyltransferase genes described above, including their promoter regions and introns but excluding repetitive elements. We report here a total of 197 genetic variations, of which 144 have not been reported before.
Materials and methods
Exon-intron boundaries of the COMT, GAMT, HNMT, NNMT, PEMT, and PNMT genes were defined by comparing genomic sequences with mRNA sequences. Accession numbers of the genomic sequences obtained for this study are as follows:
Accession numbers of the mRNA sequences are as follows:
Amplification of samples. Total genomic DNAs were isolated from peripheral leukocytes of 48 unrelated Japanese individuals by the standard phenol/chloroform extraction method. On the basis of sequence information from GenBank, we designed polymerase chain reaction (PCR) primers to amplify DNA fragments from all six genes, excluding repetitive elements, by invoking the Repeat Masker computer program in the manner described by Seki et al. (2000) . We used 60 ng of pooled DNA (20 ng from three individuals) for each PCR experiment. The reactions were performed as follows: initial denaturation at 94°C for 2 min, followed by 35 cycles of amplification at 94°C for 30s, annealing at 60°C for 1 min, and extension for 1 min.
Direct sequencing and detection of polymorphisms.
Products obtained from the PCR experiments were used as templates for direct sequencing and detection of SNPs, by the fluorescent dye-terminator cycle sequencing method (ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction Kit; PerkinElmer, Foster City, CA, USA). These procedures were carried out according to methods we have described elsewhere Seki et al. 2000; Yamada et al. 2000) .
Results
We screened 96 Japanese chromosomes for SNPs in six methyltransferase genes by direct DNA sequencing of a total of 103 kilobases of genomic DNA (11kb for the COMT gene, 5kb for GAMT, 27 kb for HNMT, 5kb for NNMT, 52 kb for PEMT, and 3 kb for PNMT). In these regions we identified a total of 190 SNPs and seven insertion/deletion polymorphisms among the six genes examined. On average, we identified one SNP in every 542 nucleotides. Fig. 1 (A-F) illustrates the location of each variation in the respective genes; detailed information about nucleotide positions and substitutions is summarized in Table 1 Among the 33 SNPs found in the COMT gene, 5 were present in the 5Ј flanking region, 21 in introns, 4 in exons, and 3 in the 3Ј flanking region. Two of the exonic SNPs would cause substitution of amino acids (Ala72Ser in exon 3 and Val158Met in exon 4); both of these variants have been reported previously in the National Center for Biotechnology Information (NCBI) dbSNP database (rs6267 and rs165688, respectively). An insertion/deletion polymorphism was found in exon 6 (rs362204) corresponding to the 3Ј untranslated region (3Ј UTR). Of the 34 genetic variations we found in this gene, 17 were novel.
Of the six SNPs found in the GAMT gene, four were present in introns and two in the 3Ј flanking region; none caused amino-acid substitutions. We were unable to find any SNPs in the 5Ј flanking region or in the regions between exons 2 and 5.
As regards the HNMT gene, one of the 41 SNPs was present in the 5Ј flanking region, 31 were in introns (20 of them in intron 5), 3 in exons, and 6 in the 3Ј flanking region. Of the three exonic SNPs, the one at codon 105 in exon 4 would cause a substitution of isoleucine for threonine. This variant had been reported previously in the NCBI dbSNP database (rs1801105). Two known SNPs were identified in the 3Ј UTR in exon 6 (rs1050891 and rs1050900).
Among the eight SNPs we found in the NNMT gene, one was in the 5Ј flanking region, six were in introns, and one was in the 3Ј flanking region.
In the PEMT gene, of the 98 SNPs found, 93 were intronic; 3 were in exons, and 2 were in the 3Ј flanking region. Two of the exonic SNPs would cause amino acid substitutions (Val58Leu in exon 5 and Ala175Thr in exon Among the four SNPs detected in the PNMT gene, two were located in the 5Ј flanking region, one in an intron, and one in the 3Ј flanking region. Both SNPs in the 5Ј flanking region were reported previously (Wu and Comings 1999) .
Discussion
We identified 197 genetic variations (190 SNPs and 7 insertion/deletion polymorphisms) by screening the entire genomic regions, except for repetitive sequences, encoding six methyltransferase genes (COMT, GAMT, HNMT, NNMT, PEMT, and PNMT) in the Japanese population. Of the 197 genetic variations detected, 144 (73%) have not been reported before (17 in the COMT gene, 2 in GAMT, 32 in HNMT, 6 in NNMT, 86 in PEMT, and 1 in PNMT).
When we investigated SNPs in these six genes using the NCBI dbSNP database, we noticed that 18 exonic SNPs in the archive were absent from our 96-chromosome Japanese population sample. Of those "missing" SNPs, eight had been reported in the COMT gene: rs1805052 (5Ј UTR) in exon 1; rs6270 (Cys34Ser) and rs740602 (Gln73Gln) in exon 3; rs769223 (Ala134Ala) in exon 4; rs769224 (Pro199Pro) and rs165631 (Leu203Leu) in exon 5; and rs12814 (3Ј UTR) and rs14968 (3Ј UTR) in exon 6. Three were in the GAMT gene: rs1050914 (Val165Phe; exon5) and rs659455 and rs659460 in the 3Ј UTR of exon 6. The archive also showed one [rs1050207 (Thr245Pro)] in exon 3 of the NNMT gene and six in exon 3 of the PNMT gene [rs5638 (Lys152Llys), rs5639 (Ser188Cys), rs5640 (Leu211His), rs5641 (Leu217Gln), rs5642 (Arg254His), and rs5643 (Trp276Arg)]. Since Yan et al. (1999) detected no SNPs or insertion/deletion events within either exons or 5Ј flanking regions of NNMT and Smith et al. (1998) reported the same result, the archived SNPs may be very rare substitutions or limited to some ethnic group, or they may reflect sequencing errors.
In the COMT gene, we identified two SNPs that caused amino acid substitutions, Ala72Ser in exon 3 and Val158Met in exon 4. Lachman et al. (1996) demonstrated that the Val158Met polymorphism in exon 4 was associated with a three-to fourfold difference in the enzyme's activity; however, it is unclear whether the Ala72Ser polymorphism in exon 3 would alter enzymatic activity. Transcription of the COMT gene is controlled by two distinct promoter regions (Tenhunen et al. 1994) ; the proximal promoter (P1), located between the S-and MB-COMT ATG start codons, regulates expression of S-COMT mRNA; MB-COMT transcription is controlled by the distal promoter (P2). We found five SNPs in the region corresponding to the P2 promoter, and one (intron 2 ϩ1140, rs6269) in the P1 promoter region. These SNPs may have some effect on transcription of the MB-COMT and S-COMT mRNAs. Since COMT is a major conjugation enzyme for the catechol iatrogenes and its genetic polymorphism is thought to correlate with its enzymic activity, a number of investigators have examined potential associations of COMT genotypes with altered susceptibilities to various diseases, for example breast cancer (Lavigne et al. 1997; Millikan et al. 1998; Thompson et al. 1998; Huang et al. 1999 ) and ovarian cancer (Goodman et al. 2000) . Some of these investigators have reported an association of the COMT genotype with risk for breast cancer, but others have found no relation between genotype and risk of either breast or ovarian cancer. The novel SNPs in COMT published here should contribute to further explorations of potential relationships between COMT allelic status and susceptibility to certain diseases.
In the GAMT gene, we found no SNP that would cause an amino acid substitution. Although mutations causing severe GAMT deficiency have been reported (Stöckler et al. 1994 (Stöckler et al. , 1996a (Stöckler et al. , 1996b (Stöckler et al. , 1997 Carducci et al. 2000; Ilas et al. 2000) , no SNPs that may correlate with diseasesusceptibility phenotypes have been reported to date.
In the HNMT gene, one SNP we detected in exon 4 would substitute an amino acid, Thr105Ile. This polymorphism, which was reported previously (Preuss et al. 1998) , has been associated with altered HNMT activity. In fact, potential associations between HNMT genotypes and susceptibility to asthma (Yan et al. 2000a ) and schizophrenia (Yan et al. 2000b) , have been investigated, but without conclusive results. Hence, the novel SNPs reported here may serve as additional tools for further exploration of possible relationships between an individual's HNMT genotype and susceptibility to certain diseases.
As regards the NNMT gene, we found no SNP causing an amino acid substitution, as previous reports have indicated as well (Smith et al. 1998; Yan et al. 1999 ). However, we detected one SNP in the 5Ј flanking region that might be capable of influencing transcriptional efficiency.
In the PEMT gene, we found two SNPs that would substitute amino acids, Val58Leu in exon 5 and Ala175Thr in exon 8, but it is unclear whether these changes would alter the enzyme's activity. However, the eight SNPs and two insertion/deletion polymorphisms we identified in intron 1, exon 2, and intron 2 might influence transcriptional efficiency.
Although we found no SNP in the PNMT gene that would cause amino acid substitution, we did identify two in the 5Ј flanking region. Since PNMT may be an important component of the mammalian stress response and is considered to be a candidate for a wide range of psychiatric disorders, the two SNPs in the putative promoter region may be useful for investigating a possible role of this gene in mental illnesses. 
